Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

UCSF-ZSFG Study Suggests ‘Non-Traditional’ Factors Drive Higher Rates

News | Stroke

Do Sexual Orientation and Gender Identity Affect Stroke Risk?

January 20, 2023 — People who identify as lesbian, gay, bisexual, transgender or non-binary may have a higher risk for s ...

January 20, 2023

Gulati Is a Renowned Expert in Preventive Cardiology and Women’s Heart Disease in the Smidt Heart Institute at Cedars-Sinai

News | Ultrasound Womens Healthcare

Martha Gulati, MD, Named Anita Dann Friedman Endowed Chair in Women’s Cardiovascular Medicine and Research

January 20, 2023 — Martha Gulati, MD, director of Preventive Cardiology and associate director of the Preventive and ...

January 20, 2023

Ralph L. Sacco, M.D., M.S., FAHA, FAAN, past president of the American Heart Association (2010-11), former editor-in-chief of the Stroke journal, formerly the University of Miami Miller School of Medicine’s chairman of neurology; the Olemberg Family Chair in Neurological Disorders; the Miller Professor of Neurology, Public Health Sciences, Human Genetics and Neurosurgery; the executive director of the Evelyn A. McKnight Brain Institute; and senior associate dean for clinical and translational science; and c

News | Cardiovascular Business

American Heart Association Grieves the Loss of Past President Ralph L. Sacco, M.D., M.S., FAHA, FAAN

January 19, 2023 — The volunteers and staff of the American Heart Association and the American Stroke Association are ...

January 19, 2023

$Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market$

News | Cardiovascular Business

Shockwave Medical Announces Agreement to Acquire Neovasc

January 19, 2023 — Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL) to treat ...

January 19, 2023

$Neovasc’s Innovative Reducer System will target the estimated $5 billion refractory angina market$

News | Structural Heart

Abbott Receives FDA Approval for Navitor TAVI System

January 19, 2023 — Abbott announced that the U.S. Food and Drug Administration (FDA) has approved the company's latest ...

January 19, 2023

Grants will provide increased opportunity for clinical research within interventional cardiology and address disparities in care

News | SCAI

SCAI Announces Recipients of Early Career Research Grants

January 18, 2023 — the Society for Cardiovascular Angiography & Interventions (SCAI) announced four recipients of their ...

January 18, 2023

Phone calls from a nurse may improve survival for patients treated for heart failure, according to a new study by investigators from the Smidt Heart Institute at Cedars-Sinai.

News | Heart Failure

Calling Patients After Heart Failure May Save Lives

January 18, 2023 — Phone calls from a nurse may improve survival for patients treated for heart failure, according to a ...

January 18, 2023

The risk of hypertension increases significantly with orthostatic circulatory disorders.

News | Hypertension

RUDN University Doctors Tested a Novel Approach to Detecting Future Arterial Hypertension in Healthy People

January 17, 2023 — Arterial hypertension(AH), or high blood pressure, can be prevented if diagnosed pre-clinically on ...

January 17, 2023

RUDN doctors analyzed the latest research on the use of RNA for the treatment and diagnosis of ischemic stroke. And, although it is too early to talk about clinical use, one of the RNAs turned out to be both a promising biomarker and a therapeutic target

News | Stroke

RNA Will Help Treat and Diagnose Ischemic Stroke

January 17, 2023 — Ischemic stroke, or cerebral infarction, ranks first in prevalence among diseases that lead to death ...

January 17, 2023

News | Heart Failure

Getting to the Heart of Chemotherapeutic Cardiotoxicity

January 16, 2023 — On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist ...

January 16, 2023

Medical center signs agreement to acquire the Company’s digital signal processing technology for arrhythmia care

News | EP Device Monitoring Systems

BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP Technology

January 13, 2023 — BioSig Technologies, Inc., an advanced digital signal processing technology company delivering ...

January 13, 2023

Patients seen at transplant centers had almost 80% higher odds to receive “bridge-to-transplant” designation

News | Heart Failure

Medicare Policy Change Could Increase Inequity in Heart Transplant Access, Study Finds

January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access ...

January 13, 2023

ADVANCE Trial compares sac regression in the Medtronic Endurant II/IIs stent graft system and the Gore® Excluder AAA Device Family systems

News | Stent Grafts

Medtronic Announces First Enrollment in Head-to-head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

January 12, 2023

SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.

News | Drug-Eluting Balloons

MedAlliance Selution SLR is the First DEB to Receive Coronary de novo IDE Approval, its Fourth FDA IDE DEB Approval

January 12, 2023 — Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA ...

January 12, 2023

Alameda, CA-based global healthcare company Penumbra has announced Food & Drug Administration (FDA) clearance and launch of Lightning Flash, which the company reports is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus.

News | Cardiovascular Business

FDA Clearance and Launch Granted to Penumbra Mechanical Thrombectomy System

January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug ...

January 11, 2023